Newsbenzinga
Akebia Says Three-Times-Weekly Vadadustat Met Primary Endpoint Of Non-Inferiority To Mircera In Hemoglobin Control In Dialysis Patients
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…